The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
997
March 28, 1997
View Complete Issue         Table of Contents 2019 
Intraurethral Alprostadil for Impotence
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Intraurethral Alprostadil for Impotence
March 28, 1997 (Issue: 997)
The prostaglandin alprostadil injected into the corpus cavernosum (Caverject - Upjohn) can produce an erection in some men with erectile dysfunction (Medical Letter, 37:83, 1995). Now a pellet (microsuppository) formulation has become available for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Intraurethral Alprostadil for Impotence
Article code: 997b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.